autologous anti-CD19 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for autologous anti-CD19 CAR-T cells, covering 2023-07-25 to 2023-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma [Phase 3]